NZ Haematology Research Review Issue 38

In this issue:

Restrictive vs. liberal blood transfusion strategy in acute MI with anaemia
Emicizumab prophylaxis for haemophilia A ±FVIII inhibitors: long-term outcomes
Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccine
Long-term VTE recurrence risk after first contraceptiverelated event
Adverse events after adding aspirin to DOACs with no clear indication
Anticoagulant therapy for SVT
Anti-PF4/polyanion antibody positivity after COVID vaccines
Cytoreductive treatment in CALR-mutated essential thrombocythaemia
Cell surface fibrinolysis impaired by reduced annexin A2 expression in VTE
Net benefit of thrombolysis in intermediate-risk PE

Please login below to download this issue (PDF)

Subscribe